Excaliard Pharmaceuticals
About:
Excaliard is a biotechnology company developing antisense drugs for the local treatment of scarring and other fibrotic diseases.
Website: http://excaliard.com
Top Investors: Alta Partners, RiverVest, ProQuest Investments
Description:
Excaliard is a newly formed, venture capital-funded biotechnology company focused on the development and commercialization of antisense drugs for the local treatment of scarring and other fibrotic diseases.
Total Funding Amount:
$15.5M
Headquarters Location:
Carlsbad, California, United States
Founded Date:
2006-01-01
Contact Email:
info(AT)excaliard.com
Founders:
Gordon Foulkes
Number of Employees:
Last Funding Date:
2007-11-27
IPO Status:
Private
Industries:
© 2025 bioDAO.ai